Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach-Reference-Cited by-同舟云学术

Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach

Published:2014-02-25 Issue:4 Volume:59 Page:1471-1481
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Mourad Abbas¹²,Deuffic-Burban Sylvie¹²,Ganne-Carrié Nathalie³,Renaut-Vantroys Thibaud⁴,Rosa Isabelle⁵,Bouvier Anne-Marie⁶,Launoy Guy⁷,Cattan Stephane⁴,Louvet Alexandre¹⁴,Dharancy Sébastien¹⁴,Trinchet Jean-Claude³,Yazdanpanah Yazdan²⁸,Mathurin Philippe¹⁴

Affiliation:

1. Inserm U995; Université Lille Nord de France; Lille France

2. IAME, UMR 1137, Inserm, Paris, France; Univ. Paris Nord Sorbonne Paris Cité; Paris France

3. Service d'Hépato-Gastroentérologie; Hôpital Jean Verdier; Bondy France

4. Service Maladies de l'Appareil digestif et de la Nutrition; Hôpital Claude Huriez; Lille France

5. ANGH CHANGH Study Group; Centre Hospitalier Intercommunal; Créteil France

6. Inserm U866; Registre des Cancers digestifs; Dijon Burgundy France

7. Inserm-UCB U1086; Caen France

8. Service des Maladies infectieuses et tropicales; Hôpital Bichat Claude Bernard; Paris France

Funder

the French National Cancer Institute (INCa), the Cancer Research Association (ARC) and the French National AIDS and Viral Hepatitis Research Agency (ANRS) teamed up to launch an Integrated Research Action Programme on hepatocellular carcinoma (HCC PAIR).

Publisher

Wiley

Subject

Hepatology

Reference46 articles.

1. Hepatocellular carcinoma;Llovet;Lancet,2003

2. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients;Fattovich;Am J Gastroenterol,2002

3. Determinants of outcome of compensated hepatitis C virus-related cirrhosis;Serfaty;Hepatology,1998

4. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer;J Hepatol,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals;Clinical Gastroenterology and Hepatology;2024-01

2. Treatment patterns, risk factors and outcomes for patients with newly diagnosed hepatocellular carcinoma in France: A retrospective database analysis;Clinics and Research in Hepatology and Gastroenterology;2023-05

3. Early cost-utility analysis of hepatitis C virus testing for emergency department attendees in France;PLOS Global Public Health;2023-02-23

4. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?;Journal of Hepatology;2023-01

5. Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach;Hepatology Communications;2022-08-25